“Based on the amazing work that the Gamaleya Institute is conducting, we see interest not even from 20-30, but from 40 countries,” RIA Novosti Dmitriev quotes.

He said that at present "it is precisely the big focus on the fact that production facilities in Russia will initially serve only the Russian market."

“We are focused on being able to supply the vaccine to foreign markets, produced outside of Russia, already in November this year, thanks to the wonderful technology developed by the Gamaleya Institute,” he added.

Earlier, Denis Logunov, deputy director of the Gamaleya Center for Research, said that the Sputnik V vaccine against coronavirus infection COVID-19 has been delivered to medical centers, where vaccination of volunteers will begin in the near future.

Doctor of Biological Sciences, Professor of Moscow State University named after M.V.

Lomonosov, Alexey Agranovsky, in an interview with the FAN, commented on the development of a vaccine against COVID-19 by Russian scientists.